Search clinical trials for: Multiple Dose Group: Belimumab SC 2 x 120 mg weekly
Total 18 results
-
Human Genome Sciences Inc.GlaxoSmithKlineCompleted
-
Oslo University HospitalTakeda Nycomed; Sykehuset Asker og BaerumCompleted
-
University of MichiganFood and Drug Administration (FDA)CompletedLocal Drug Concentration in Gastrointestinal TractUnited States
-
University Hospital, GhentCompletedErosive Osteo-ArthritisBelgium
-
Spanish Clinical Pharmacology SocietySpanish reumatology SocietyCompleted
-
University Health Network, TorontoActive, not recruitingAxial SpondyloarthritisCanada
-
AstraZenecaCompletedHypertriglyceridemiaUnited States
-
University of PittsburghGenentech, Inc.Completed
-
Poitiers University HospitalCompletedKidney TransplantationFrance
-
Assaf-Harofeh Medical CenterUnknownPeritoneal Dialysis | ESRDIsrael
-
Actavis Inc.Completed
-
Fundación Leucemia y Linfoma, SpainRoche Pharma AGCompletedNon-Hodgkin's LymphomaSpain
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedLeukemia | Acute Lymphoblastic LeukemiaUnited States
-
Rabin Medical CenterTel Aviv University; The Leona M. and Harry B. Helmsley Charitable TrustRecruiting
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States
-
OHSU Knight Cancer InstituteAbbVie; Oregon Health and Science UniversityRecruitingB Acute Lymphoblastic Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Mixed Phenotype Acute LeukemiaUnited States